FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588131865> ?p ?o ?g. }

• W2588131865 endingPage "2679" @default.
• W2588131865 startingPage "2671" @default.
• W2588131865 abstract "Among bone morphogenetic protein (BMP) family members, BMP-2 and BMP-9 have demonstrated potent osteoinductive potential. However, in vivo differences in their potential for bone regeneration remain unclear. The present study aimed to compare the effects of recombinant human (rh) BMP-2 and rhBMP-9 on bone formation in rat calvarial critical-size defects (CSD). Twenty-eight Wistar rats surgically received two calvarial defects bilaterally in each parietal bone. Defects (n = 56) were allocated into four groups: absorbable collagen sponge (ACS) alone, rhBMP-2 with ACS (rhBMP-2/ACS), rhBMP-9/ACS, or sham surgery (control), on the condition that the treatments of rhBMP-2/ACS and rhBMP-9/ACS, or the same treatments were not included in the same animal. Animals were sacrificed at 2 and 8 weeks post-surgery. The calvarial defects were analyzed for bone volume (BV) by micro-computed tomography and for percentages of defect closure (DC/DL), newly formed bone area (NBA/TA), bone marrow area (BMA/NBA), adipose tissue area (ATA/NBA), central bone height (CBH), and marginal bone height (MBH) by histomorphometric analysis. The BV in the rhBMP-2/ACS group (5.44 ± 3.65 mm3, n = 7) was greater than the other groups at 2 weeks post-surgery, and the rhBMP-2/ACS and rhBMP-9/ACS groups (18.17 ± 2.51 and 16.30 ± 2.46 mm3, n = 7, respectively) demonstrated significantly greater amounts of BV compared with the control and ACS groups (6.02 ± 2.90 and 9.30 ± 2.75 mm3, n = 7, respectively) at 8 weeks post-surgery. The rhBMP-2/ACS and rhBMP-9/ACS groups significantly induced new bone formation compared to the control and ACS groups at 8 weeks post-surgery. However, there were no statistically significant differences found between the rhBMP-2/ACS and rhBMP-9/ACS groups in any of the histomorphometric parameters. The ATA/NBA in the rhBMP-2/ACS group (9.24 ± 3.72%, n = 7) was the highest among the treatment groups at 8 weeks post-surgery. Within the limits of this study, it can be concluded that rhBMP-2/ACS induced a slight early increase in new bone formation at 2 weeks and that rhBMP-9/ACS provided comparable new bone formation to rhBMP-2/ACS with less adipose tissues after a healing period of 8 weeks in rat CSD. RhBMP-9/ACS treatment provided new bone formation with less adipose tissues compared with rhBMP-2/ACS." @default.
• W2588131865 created "2017-02-24" @default.
• W2588131865 creator A5014993685 @default.
• W2588131865 creator A5017575279 @default.
• W2588131865 creator A5030470473 @default.
• W2588131865 creator A5051037094 @default.
• W2588131865 creator A5069537921 @default.
• W2588131865 creator A5072733440 @default.
• W2588131865 creator A5080871072 @default.
• W2588131865 date "2017-02-14" @default.
• W2588131865 modified "2023-10-16" @default.
• W2588131865 title "Comparison of the effects of recombinant human bone morphogenetic protein-2 and -9 on bone formation in rat calvarial critical-size defects" @default.
• W2588131865 cites W1543052044 @default.
• W2588131865 cites W1962351050 @default.
• W2588131865 cites W1967770421 @default.
• W2588131865 cites W1969989929 @default.
• W2588131865 cites W1974735490 @default.
• W2588131865 cites W1983387751 @default.
• W2588131865 cites W1991790884 @default.
• W2588131865 cites W1997136944 @default.
• W2588131865 cites W1998450715 @default.
• W2588131865 cites W2002569536 @default.
• W2588131865 cites W2002942855 @default.
• W2588131865 cites W2003098906 @default.
• W2588131865 cites W2011490281 @default.
• W2588131865 cites W2028050465 @default.
• W2588131865 cites W2029145815 @default.
• W2588131865 cites W2033954341 @default.
• W2588131865 cites W2037479602 @default.
• W2588131865 cites W2039586057 @default.
• W2588131865 cites W2039813962 @default.
• W2588131865 cites W2040121303 @default.
• W2588131865 cites W2041909276 @default.
• W2588131865 cites W2046833545 @default.
• W2588131865 cites W2057408046 @default.
• W2588131865 cites W2065626035 @default.
• W2588131865 cites W2066355783 @default.
• W2588131865 cites W2067119056 @default.
• W2588131865 cites W2069553296 @default.
• W2588131865 cites W2069636601 @default.
• W2588131865 cites W2069667907 @default.
• W2588131865 cites W2079362431 @default.
• W2588131865 cites W2084252955 @default.
• W2588131865 cites W2086054038 @default.
• W2588131865 cites W2098389224 @default.
• W2588131865 cites W2102912402 @default.
• W2588131865 cites W2116668498 @default.
• W2588131865 cites W2120032969 @default.
• W2588131865 cites W2123265528 @default.
• W2588131865 cites W2127766913 @default.
• W2588131865 cites W2146414049 @default.
• W2588131865 cites W2152947053 @default.
• W2588131865 cites W2162629970 @default.
• W2588131865 cites W2170651583 @default.
• W2588131865 cites W2266078859 @default.
• W2588131865 cites W2280022771 @default.
• W2588131865 cites W2295812166 @default.
• W2588131865 cites W2329311838 @default.
• W2588131865 cites W2334811311 @default.
• W2588131865 cites W2408896716 @default.
• W2588131865 cites W2460771438 @default.
• W2588131865 cites W2481932511 @default.
• W2588131865 cites W2530187156 @default.
• W2588131865 cites W2605187236 @default.
• W2588131865 doi "https://doi.org/10.1007/s00784-017-2069-3" @default.
• W2588131865 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28197731" @default.
• W2588131865 hasPublicationYear "2017" @default.
• W2588131865 type Work @default.
• W2588131865 sameAs 2588131865 @default.
• W2588131865 citedByCount "28" @default.
• W2588131865 countsByYear W25881318652017 @default.
• W2588131865 countsByYear W25881318652018 @default.
• W2588131865 countsByYear W25881318652019 @default.
• W2588131865 countsByYear W25881318652020 @default.
• W2588131865 countsByYear W25881318652021 @default.
• W2588131865 countsByYear W25881318652022 @default.
• W2588131865 countsByYear W25881318652023 @default.
• W2588131865 crossrefType "journal-article" @default.
• W2588131865 hasAuthorship W2588131865A5014993685 @default.
• W2588131865 hasAuthorship W2588131865A5017575279 @default.
• W2588131865 hasAuthorship W2588131865A5030470473 @default.
• W2588131865 hasAuthorship W2588131865A5051037094 @default.
• W2588131865 hasAuthorship W2588131865A5069537921 @default.
• W2588131865 hasAuthorship W2588131865A5072733440 @default.
• W2588131865 hasAuthorship W2588131865A5080871072 @default.
• W2588131865 hasBestOaLocation W25881318652 @default.
• W2588131865 hasConcept C104317684 @default.
• W2588131865 hasConcept C126322002 @default.
• W2588131865 hasConcept C141071460 @default.
• W2588131865 hasConcept C185592680 @default.
• W2588131865 hasConcept C199343813 @default.
• W2588131865 hasConcept C202751555 @default.
• W2588131865 hasConcept C2779300802 @default.
• W2588131865 hasConcept C2780322005 @default.
• W2588131865 hasConcept C2993291840 @default.
• W2588131865 hasConcept C2993373878 @default.
• W2588131865 hasConcept C30352789 @default.
• W2588131865 hasConcept C31507581 @default.

• next